by Benzinga Insights | Sep 23, 2026 | General
Credicorp (NYSE:BAP) has outperformed the market over the past 20 years by 2.6% on an annualized basis producing an average annual return of 11.76%. Currently, Credicorp has a market capitalization of $30.61 billion. Buying $100 In BAP: If an investor had bought $100...
by Benzinga Insights | Sep 23, 2026 | General
Watts Water Technologies (NYSE:WTS) has outperformed the market over the past 5 years by 3.78% on an annualized basis producing an average annual return of 15.88%. Currently, Watts Water Technologies has a market capitalization of $11.91 billion. Buying $100 In WTS:...
by Benzinga Insights | Sep 23, 2026 | General
MKS (NASDAQ:MKSI) has outperformed the market over the past 15 years by 4.48% on an annualized basis producing an average annual return of 17.9%. Currently, MKS has a market capitalization of $17.67 billion. Buying $1000 In MKSI: If an investor had bought $1000 of...
by Adam Eckert | Sep 23, 2026 | General
Viking Therapeutics Inc (NASDAQ:VKTX) shares are moving lower in extended trading Wednesday after the company announced a pair of proposed public offerings. Viking Therapeutics stock is showing upward bias. What should traders watch with VKTX? Viking Therapeutics...
by Erica Kollmann | Sep 23, 2026 | General
Viking Therapeutics (NASDAQ:VKTX) shares are surging after the company reported positive results for its weight-loss drug candidate — the stock gained over 40% in two days. • Vertex Pharmaceuticals stock is trading near recent highs. What’s next for VRTX stock? Vk2735...
Recent Comments